The International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008
Rosenthal, Victor D., Maki, Dennis G., Mehta, Ajita, Álvarez-Moreno, Carlos, Leblebicioglu, Hakan, Higuera, Francisco, Cuellar, Luis E., Madani, Naoufel, Zan, Mitrev, Dueñas, Lourdes, Navoa-Ng, Josephine Anne, Garcell, Humberto Guanche, Raka, Lul, Fernández Hidalgo, Rosalía, Medeiros, Eduardo A., Kanj, Souha S., Abubakar, Salisu, Nercelles, Patricio, Diez Pratesi, Ricardo, Graves, Nicholas, & (see Appendix for rest of the authors) (2008) The International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. American Journal of Infection Control, 36(9), pp. 627-637.
We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from 2002 through 2007in 98 intensive care units (ICU's) in Latin America, Asia, Africa, and Europe. During the 6-year study, using Centers for Disease Controland Prevention (CDC) National Nosocomial Infections Surveillance System (NNIS) definitions for device-associated health care-associated infection, we collected prospective data from 43,114 patients hospitalized in the Consortium's hospital for an aggregate of 272, 279 days. Although device utilization in the INICC ICU's was remarkably similar to that reported from US ICU's in the CDC's National Healthcare Safety Network, rates of device-associated nosocomial infection were markedly higher in the ICU's of the INICC hospitals: the pooled rate of central line-associated bloodstream infections (CLABs)in the INICC ICU's, 9.2 per 1000 CL-days, is nearly 3-fold higher than the 2.4-5.3 per 1000 CL-days reported from comparable US ICUs, and the overall rate of ventilator-associated pneumonia was also higher, 19.5 vs 1.1-3.6 per 1000 ventilator-days, as was the rate of catheter-associated urinary tract infection, 6.5 versus3.4-5.2 per 1000 catheter-days. Most strikingly, the frequencies of resistance of staphylococcus aureus isolates to methicillin (MRSA) (80.8% vs 48.1%), Enterobacterspecies to ceftriaxone (50.8% vs 17.8%, and Pseudomonas aeruginosa to Fluoroquinolones (52.4% vs29.1%)were also higher in the Consortium ICU's, and the crude unadjusted excess mortalities of device-related infections rangedfrom 14.3% (CLABs) to 27.5% (ventilator-associated pneumonia). (Am J Infect Control 2008; 36: 627-37.)
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||Healthcare acquired infection|
|Subjects:||Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > MEDICAL MICROBIOLOGY (110800) > Medical Infection Agents (incl. Prions) (110802)
Australian and New Zealand Standard Research Classification > ECONOMICS (140000) > APPLIED ECONOMICS (140200) > Health Economics (140208)
|Divisions:||Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
Current > Schools > School of Public Health & Social Work
|Deposited On:||30 Apr 2009 22:39|
|Last Modified:||29 Feb 2012 13:49|
Repository Staff Only: item control page